---
schema_version: "secwatch.filing_event.v1"
accession: "0001549595-24-000073"
form_type: "8-K"
ticker: "NRIX"
cik: "0001549595"
company_name: "Nurix Therapeutics, Inc."
filed_at: "2024-05-21T23:59:59+00:00"
generated_at: "2026-06-01T10:52:05.381525+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Nurix Therapeutics annual meeting: stockholders elect directors, ratify auditor, approve say-on-pay

## Summary
- Stockholders elected directors Julia P. Gregory (29.9M for, 4.5M withheld) and David L. Lacey (27.1M for, 7.3M withheld) to terms expiring 2027.
- Ratified PricewaterhouseCoopers LLP as independent auditor for FY ending Nov 30, 2024 (39.0M for, 16.7K against).
- Non-binding advisory vote on named executive officer compensation passed: 30.4M for, 4.0M against, 77.4K abstentions.

## SEC filing metadata
- accession: 0001549595-24-000073
- form_type: 8-K
- ticker: NRIX
- cik: 0001549595
- company_name: Nurix Therapeutics, Inc.
- filed_at: 2024-05-21T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1549595/000154959524000073/0001549595-24-000073-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1549595/000154959524000073/nrix-20240520.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001549595-24-000073
- JSON: https://secwatch.observer/filing/0001549595-24-000073.json
- Plain text: https://secwatch.observer/filing/0001549595-24-000073.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.